JOURNAL OF NEURO-ONCOLOGY

简称 J NEURO-ONCOL ·UNITED STATES ·出版周期 Monthly ·年均收录 306 篇

3.1

最新影响因子

8.50%

自引率

约75%

投稿难度

平均3.3月

审稿周期

期刊简介

JOURNAL OF NEURO-ONCOLOGY是一本专注于神经肿瘤学领域的国际学术期刊，ISSN号为0167-594X，由Springer出版社出版，出版地为美国，出版周期为月刊。该期刊的影响因子根据最新数据在神经肿瘤学领域处于中等偏上水平，目前不是开放获取（OA）期刊，但提供混合出版选项。它被SCI收录，并且在中科院分区中通常位于医学或肿瘤学领域的3区或4区。该期刊的发文特点主要集中在神经肿瘤的基础与临床研究，包括脑瘤、脊髓肿瘤的诊断、治疗和分子机制等方向，尤其关注多学科交叉研究。其质量在专业领域内有一定认可度，但近年来由于竞争加剧和审稿标准波动，存在一定的投稿风险，例如审稿周期较长或拒稿率较高，建议投稿前仔细评估研究内容与期刊范围的匹配度。

影响因子趋势

近期发表

Assessing the personal financial impact of vestibular schwannoma management 2026-09-10

Treatment selection or treatment effect? Interpreting functional outcomes in motor cortex metastases 2026-09-08

Annexin A2 associated with bevacizumab resistance and infiltrative escape in glioblastoma 2026-09-03

Prognostic significance of walking ability at hospital discharge for overall survival in newly diagnosed glioblastoma: a comparison across six peri-treatment assessments 2026-09-11

α-Synuclein suppresses glioma progression through the CDH13–JNK/c-Jun pathway 2026-09-01

Contrast enhancement: the missing imaging variable in IDH-wildtype gliomas with historical WHO grade 2 and 3 histology 2026-09-09

Prognostic value of the Evans index in neoplastic meningitis: a real-world cohort study 2026-09-07

Therapeutic hybrid intelligence with neural and knowledge-based expert reasoning for SRS (THINKERS): a mixture-of-experts framework for gastrointestinal brain metastases 2026-09-02

Diffusion histogram analysis predicts progression-free survival in contrast enhancing recurrent IDH mutant gliomas treated with bevacizumab 2026-09-09

Stereotactic radiosurgery for brain metastases from male breast cancer: a multicenter retrospective study 2026-09-09